EVOLUS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
EVOLUS, INC. (EOLS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.07 million shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2019-05-01
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-03-31 was 4.07M shares, a 122.62% increase year-over-year.
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-09-30 was 355.00K shares.
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-06-30 was 1.08M shares.
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2018-03-31 was 1.83M shares.
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 3.48M shares.
- EVOLUS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 0.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2019-03-31 | 4.07M shares 10-Q · filed 2019-05-01 | |||
| 2018-12-31 | 3.48M shares 10-K · filed 2019-03-20 | |||
| 2018-09-30 | 355.00K shares 10-Q · filed 2018-11-05 | 3.26M shares 10-Q · filed 2018-11-05 | ||
| 2018-06-30 | 1.08M shares 10-Q · filed 2018-08-02 | 2.91M shares 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | 1.83M shares 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | 0.00 shares 10-K · filed 2019-03-20 | |||
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-11-05 | 0.00 shares 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-02 | 0.00 shares 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |